CLOCK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.65799999998872E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.17999999996277E-06 |
Normal-vs-Stage2 |
2.556200E-02 |
Normal-vs-Stage3 |
1.348320E-02 |
Normal-vs-Stage4 |
8.678500E-02 |
Stage1-vs-Stage2 |
6.163200E-01 |
Stage1-vs-Stage3 |
5.257000E-01 |
Stage1-vs-Stage4 |
9.529400E-01 |
Stage2-vs-Stage3 |
9.646200E-01 |
Stage2-vs-Stage4 |
7.939600E-01 |
Stage3-vs-Stage4 |
7.574800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.94129999994986E-06 |
Normal-vs-AfricanAmerican |
3.85419999999748E-05 |
Normal-vs-Asian |
5.219800E-04 |
Caucasian-vs-AfricanAmerican |
5.991800E-01 |
Caucasian-vs-Asian |
3.736400E-01 |
AfricanAmerican-vs-Asian |
4.462400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.43459999832641E-08 |
Normal-vs-Female |
2.144600E-01 |
Male-vs-Female |
7.173600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.236430E-03 |
Normal-vs-Extreme_Weight |
4.3663999971244E-08 |
Normal-vs-Obese |
2.643300E-03 |
Normal-vs-Extreme_Obese |
4.35130000000505E-05 |
Normal_Weight-vs-Extreme_Weight |
2.523600E-01 |
Normal_Weight-vs-Obese |
4.115400E-01 |
Normal_Weight-vs-Extreme_Obese |
2.306400E-01 |
Extreme_Weight-vs-Obese |
1.750400E-02 |
Extreme_Weight-vs-Extreme_Obese |
7.317200E-01 |
Obese-vs-Extreme_Obese |
3.342200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.211500E-02 |
Normal-vs-Age(41-60Yrs) |
8.029600E-04 |
Normal-vs-Age(61-80Yrs) |
1.85979999955954E-07 |
Normal-vs-Age(81-100Yrs) |
1.562570E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.468800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.718000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.121600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.812100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.387000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.705800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.39890000028231E-07 |
Normal-VS-Type2 PRCC |
2.194700E-04 |
Normal-VS-KIRP CIMP |
5.824200E-01 |
Normal-VS-Unclassified PRCC |
1.731830E-01 |
Type1 PRCC-VS-Type2 PRCC |
2.682200E-01 |
Type1 PRCC-VS-KIRP CIMP |
8.135800E-02 |
Type1 PRCC-VS-Unclassified PRCC |
1.445990E-02 |
Type2 PRCC-VS-KIRP CIMP |
2.446800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.604430E-01 |
KIRP CIMP-VS-Unclassified PRCC |
8.323200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.04299999998037E-06 |
Normal-vs-N1 |
5.832200E-02 |
Normal-vs-N2 |
3.870200E-01 |
N0-vs-N1 |
1.813770E-01 |
N0-vs-N2 |
6.676800E-01 |
N1-vs-N2 |
8.449800E-01 |
|
|